Versifel FeLV,suspension for injection for cats
Versifel FeLV,suspension for injection for cats
Authorised
- Feline leukemia virus, strain Kawakami-Theilen, glycoprotein gp70
Product identification
Medicine name:
Versifel FeLV, suspension for injection
Versifel FeLV,suspension for injection for cats
Active substance:
- Feline leukemia virus, strain Kawakami-Theilen, glycoprotein gp70
Target species:
-
Cat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Feline leukemia virus, strain Kawakami-Theilen, glycoprotein gp708.10/log2 geometric mean titre1.00Dose
Pharmaceutical form:
-
Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI06AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Available in:
-
Ireland
Package description:
- (ID2): 1 Box with 25 Bottle (Glass) with 1 Dose (25 Dose)
- (ID1): 1 Box with 10 Bottle (Glass) with 1 Dose (10 Dose)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10387/088/001
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0254/001
Concerned member states:
-
Austria
-
Belgium
-
Cyprus
-
France
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Luxembourg
-
Poland
-
Portugal
-
Romania
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
